Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 3.60% is 183% above its 5-year average of -4.36%, near the high end of its 5-year range (-45.76%–14.61%).
676.57% above its 12-month average of -0.62%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.41%.
NET PROFIT MARGIN
3.60%
NET PROFIT MARGIN AVG TTM
-0.62%
NET PROFIT MARGIN AVG 3Y
-0.61%
NET PROFIT MARGIN AVG 5Y
-4.36%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+676.57%
CURRENT VS 3Y AVG
+685.89%
CURRENT VS 5Y AVG
+182.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-60.89%
vs the sector median at left
Oscar Health, Inc.
Market Cap
$8.33B
Net Profit Margin
3.60%
TTM Avg
-0.62%
3Y Avg
-0.61%
5Y Avg
-4.36%
Market Cap
$9.66B
Net Profit Margin
2.96%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
Market Cap
$9.99B
Net Profit Margin
17.03%
TTM Avg
11.20%
3Y Avg
12.20%
5Y Avg
12.89%
Market Cap
$6.59B
Net Profit Margin
10.60%
TTM Avg
11.45%
3Y Avg
11.66%
5Y Avg
12.42%
Market Cap
$10.13B
Net Profit Margin
8.59%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
Market Cap
$10.14B
Net Profit Margin
6.90%
TTM Avg
6.89%
3Y Avg
6.71%
5Y Avg
6.89%
Market Cap
$6.24B
Net Profit Margin
-5.51%
TTM Avg
7.00%
3Y Avg
-0.29%
5Y Avg
-8.82%
Market Cap
$10.48B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $8.33B | 3.60% | -0.62% | -0.61% | -4.36% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 2.96% | 3.05% | 3.43% | 3.79% |
| Insulet Corp. (PODD)vs › | $9.74B | 12.29% | 14.66% | 10.46% | 7.35% |
| Globus Medical, Inc. (GMED)vs › | $9.99B | 17.03% | 11.20% | 12.20% | 12.89% |
| Chemed Corporation (CHE)vs › | $6.59B | 10.60% | 11.45% | 11.66% | 12.42% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.13B | 8.59% | -21.22% | -48.94% | 16.61% |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 6.90% | 6.89% | 6.71% | 6.89% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | -5.51% | 7.00% | -0.29% | -8.82% |
| Molina Healthcare, Inc. (MOH)vs › | $10.48B | -0.02% | 1.97% | 2.41% | 2.58% |
| Align Technology, Inc. (ALGN)vs › | $10.57B | 9.99% | 10.36% | 10.48% | 22.21% |
Operating Margin
4.1%
Net Profit Margin
3.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 7.41% |
| 2026-03-31 | 14.61% |
| 2025-12-31 | -12.57% |
| 2025-09-30 | -4.60% |
| 2025-06-30 | -7.97% |
| 2025-03-31 | 9.04% |
| 2024-12-31 | -6.42% |
| 2024-09-30 | -2.25% |
| 2024-06-30 | 2.53% |
| 2024-03-31 | 8.28% |
| 2023-12-31 | -10.48% |
| 2023-09-30 | -4.54% |
| 2023-06-30 | -1.02% |
| 2023-03-31 | -2.71% |
| 2022-12-31 | -21.78% |
| 2022-09-30 | -18.94% |
| 2022-06-30 | -10.60% |
| 2022-03-31 | -7.43% |
| 2021-12-31 | -38.33% |
| 2021-09-30 | -45.76% |
| 2021-06-30 | -13.34% |
| 2021-03-31 | -22.87% |
| 2020-12-31 | -101.19% |
| 2020-09-30 | -59.36% |
| 2020-06-30 | -28.13% |
| 2020-03-31 | -78.68% |
